Lipiodol Ultra-fluide, Injektionslösung

7680302740243 CH-30274 Injektionslösung
Lipiodol Ultra-fluide, Injektionslösung
Lipiodol Ultra-fluide, Injektionslösung
Lipiodol Ultra-fluide, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/02/2025
Summary of Product Characteristics
Français
04/02/2025
Summary of Product Characteristics
Italien
04/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
4.8 G Substance Wirkstoff (Principe actif)
(N/A)
10.0 ML Substance WIZUS
(N/A)
3.85 MG Substance HBESI
(N/A)
1.4 MG Substance HBESI

Authorization holder

Guerbet AG

8050 Zürich

Authorization information

Swissmedic authorization number
30274
Drug name
Lipiodol Ultra-fluide, Injektionslösung
Galenic form
LSPA
ATC Code
V08AD01
Authorization status
Z
Dispensing category
B
First authorization
24/09/1964
Authorization expiration date
31/12/9999
IT Number
14.01.0.
Domain
Human medicine
Field of application
Lymphographie, transarterielle Chemoembolisation

Package details

Description (FR)
LIPIODOL Ultra-fluide sol inj 4.8 g/10ml amp 10 ml
Description (DE)
LIPIODOL Ultra-fluide Inj Lös 4.8 g/10ml Amp 10 ml
Market launch
12/06/2003
Narcotic (BTM)
No